Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Littoral cell angioma of the spleen: a study of 25 cases with confirmation of frequent association with visceral malignancies

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064173%3A_____%2F16%3AN0000140" target="_blank" >RIV/00064173:_____/16:N0000140 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/00216208:11140/16:10330674 RIV/00216208:11120/16:43911994 RIV/00669806:_____/16:10330674

  • Výsledek na webu

    <a href="http://dx.doi.org/10.1111/his.13026" target="_blank" >http://dx.doi.org/10.1111/his.13026</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/his.13026" target="_blank" >10.1111/his.13026</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Littoral cell angioma of the spleen: a study of 25 cases with confirmation of frequent association with visceral malignancies

  • Popis výsledku v původním jazyce

    BACKGROUND: Littoral cell angioma (LCA) is a rare primary splenic tumor frequently associated with internal malignancies. Immunohistochemistry (IHC) can prove a distinct hybrid endothelial/histiocytic phenotype of littoral cells and is a helpful adjunct to render the correct diagnosis. We present a series of 25 LCA with an emphasis on the frequent association of the neoplasm with visceral malignancies and provide a detailed immunohistochemical analysis by employing new markers. DESIGN: All 25 cases with available tissue blocks were immunohistochemically stained for endothelial and histiocytic markers. Clinical data and follow-up were retrieved from respective institutions. RESULTS: The tumors were obtained from 16 males and 9 females, whose age ranged from 32 to 86 years (mean 56.2 yrs). Clinical information was available for 24/25 patients and follow-up for 11/25 patients (range 2-19 years; mean 11.6). Immunohistochemically, all cases were positive for LYVE 1, FVIII, Fli-1, VEGFR 2, VEGFR 3, Claudin-5, ERG, LMO2, CD31, CD163, Lysozyme, and CD4, but were negative for D2-40, CD8 and Factor XIIIa. 15/25 cases were associated with various malignancies including epithelial, mesenchymal and hematological tumors. CONCLUSIONS: The cohort of 25 patients is the largest series of LCA published to date. Using antibodies to recently introduced endothelial markers we have expanded the immunoprofile of LCA. We have further highlighted the clinical significance of LCA, inasmuch as more than half of the patients in this study also harbored a co-existent visceral malignancy. Therefore, we conclude that the finding of splenic LCA mandates a thorough clinical evaluation for a concomitant malignancy.

  • Název v anglickém jazyce

    Littoral cell angioma of the spleen: a study of 25 cases with confirmation of frequent association with visceral malignancies

  • Popis výsledku anglicky

    BACKGROUND: Littoral cell angioma (LCA) is a rare primary splenic tumor frequently associated with internal malignancies. Immunohistochemistry (IHC) can prove a distinct hybrid endothelial/histiocytic phenotype of littoral cells and is a helpful adjunct to render the correct diagnosis. We present a series of 25 LCA with an emphasis on the frequent association of the neoplasm with visceral malignancies and provide a detailed immunohistochemical analysis by employing new markers. DESIGN: All 25 cases with available tissue blocks were immunohistochemically stained for endothelial and histiocytic markers. Clinical data and follow-up were retrieved from respective institutions. RESULTS: The tumors were obtained from 16 males and 9 females, whose age ranged from 32 to 86 years (mean 56.2 yrs). Clinical information was available for 24/25 patients and follow-up for 11/25 patients (range 2-19 years; mean 11.6). Immunohistochemically, all cases were positive for LYVE 1, FVIII, Fli-1, VEGFR 2, VEGFR 3, Claudin-5, ERG, LMO2, CD31, CD163, Lysozyme, and CD4, but were negative for D2-40, CD8 and Factor XIIIa. 15/25 cases were associated with various malignancies including epithelial, mesenchymal and hematological tumors. CONCLUSIONS: The cohort of 25 patients is the largest series of LCA published to date. Using antibodies to recently introduced endothelial markers we have expanded the immunoprofile of LCA. We have further highlighted the clinical significance of LCA, inasmuch as more than half of the patients in this study also harbored a co-existent visceral malignancy. Therefore, we conclude that the finding of splenic LCA mandates a thorough clinical evaluation for a concomitant malignancy.

Klasifikace

  • Druh

    J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

  • CEP obor

    EB - Genetika a molekulární biologie

  • OECD FORD obor

Návaznosti výsledku

  • Projekt

  • Návaznosti

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Ostatní

  • Rok uplatnění

    2016

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Histopathology

  • ISSN

    0309-0167

  • e-ISSN

  • Svazek periodika

    69

  • Číslo periodika v rámci svazku

    5

  • Stát vydavatele periodika

    GB - Spojené království Velké Británie a Severního Irska

  • Počet stran výsledku

    13

  • Strana od-do

    762-774

  • Kód UT WoS článku

    000388300800005

  • EID výsledku v databázi Scopus

    2-s2.0-84982286043